Burke Steven Keith

Track

Insider profile

Performance

Overall performance
3.6
Performance over holding periods
3.6
30 days 90 days 120 days
Average return 10% 8.2% 15.1%
Success rate 65% 68% 82%
Transactions
12 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Burke Steven Keith's trades of Akebia Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-04 2026-02-02
PlS Planned sale
12,266 +7.2%
328.74
US$1,922,656 		12,266 +7.2% 328.74 US$1,922,656
2026-02-04 2026-02-02
PlS Planned sale
26,472 +3.5%
455.92
US$1,654,712 		26,472 +3.5% 455.92 US$1,654,712
2026-02-04 2026-02-02
PlS Planned sale
14,278 +0.6%
235.11
US$2,195,974 		14,278 +0.6% 235.11 US$2,195,974
2026-02-04 2026-02-02
PlS Planned sale
25,375 -2.6%
1.39
US$35,271 		25,375 -2.6% 1.39 US$35,271
2026-02-04 2026-02-02
PlS Planned sale
21,582 -2.1%
1.39
US$29,999 		21,582 -2.1% 1.39 US$29,999
2026-02-02 2026-02-02
PrS Proposed sale
67,658
1.39
US$94,349 		67,658 1.39 US$94,349
2025-03-04 2025-03-03
PlS Planned sale
7,144 -0.9%
1.83
US$13,074 		7,144 -0.9% 1.83 US$13,074
2025-03-03 2025-03-03
PrS Proposed sale
7,144
1.83
US$13,086 		7,144 1.83 US$13,086
2025-02-04 2025-02-03
PlS Planned sale
27,236 -3.2%
2.10
US$57,196 		27,236 -3.2% 2.10 US$57,196
2025-02-04 2025-02-03
PlS Planned sale
23,270 -2.7%
2.10
US$48,867 		23,270 -2.7% 2.10 US$48,867
2025-02-03 2025-02-03
PrS Proposed sale
50,506
2.10
US$106,295 		50,506 2.10 US$106,295
2024-03-01 2024-02-29
S Sale
7,169 -1.0%
1.58
US$11,327 		7,169 -1.0% 1.58 US$11,327
2024-02-29 2024-02-29
PrS Proposed sale
7,169
1.58
US$11,301 		7,169 1.58 US$11,301
2024-02-29 2024-02-27
PlS Planned sale
8,367 -1.2%
1.52
US$12,718 		8,367 -1.2% 1.52 US$12,718
2024-02-27 2024-02-27
PrS Proposed sale
8,367
1.52
US$12,695 		8,367 1.52 US$12,695
2024-02-02 2024-02-01
S Sale
24,311 -3.3%
1.68
US$40,842 		24,311 -3.3% 1.68 US$40,842
2024-02-01 2024-02-01
PrS Proposed sale
24,311
1.68
US$40,767 		24,311 1.68 US$40,767
2024-05-09 2023-08-25
S Sale
27,000 -3.9%
1.15
US$31,050 		27,000 -3.9% 1.15 US$31,050
2023-05-18 2023-05-16
S Sale
63,567 -10.7%
1.07
US$67,890 		63,567 -10.7% 1.07 US$67,890
2023-05-16 2023-05-16
PrS Proposed sale
63,567
1.07
US$67,890 		63,567 1.07 US$67,890
2023-03-03 2023-03-01
S Sale
1,110 -0.2%
0.88
US$974 		1,110 -0.2% 0.88 US$974
2023-03-03 2023-03-01
S Sale
6,400 -1.1%
0.88
US$5,616 		6,400 -1.1% 0.88 US$5,616
2023-03-03 2023-03-01
S Sale
6,613 -1.1%
0.88
US$5,803 		6,613 -1.1% 0.88 US$5,803
2023-03-01 2023-02-27
S Sale
7,539 -1.2%
0.81
US$6,131 		7,539 -1.2% 0.81 US$6,131
2022-09-01 2022-08-31
PlS Planned sale
1,147 -0.3%
0.36
US$416 		1,147 -0.3% 0.36 US$416
2022-03-02 2022-03-01
PlS Planned sale
1,100 -0.5%
2.17
US$2,388 		1,100 -0.5% 2.17 US$2,388
2022-03-02 2022-03-01
S Sale
6,556 -2.9%
2.17
US$14,231 		6,556 -2.9% 2.17 US$14,231
2022-03-02 2022-02-28
S Sale
7,400 -4.3%
2.15
US$15,946 		7,400 -4.3% 2.15 US$15,946
2021-04-01 2021-04-01
S Sale
1,081 -0.6%
3.40
US$3,675 		1,081 -0.6% 3.40 US$3,675
2021-03-02 2021-03-01
S Sale
7,558 -4.5%
3.40
US$25,668 		7,558 -4.5% 3.40 US$25,668